EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases

Yufeng Hu iD, Wei Li, Xu Cheng, Hailong Yang iD, Zhi-Gang She iD, Jingjing Cai iD, Hongliang Li iD, Xiao-Jing Zhang

Circulation Research · 21.06.2024 · 135 (1) · 222-260

DOI: 10.1161/circresaha.124.324383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 21.06.2024. Verfasst von Yufeng Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institut…. Hauptthemen laut MEDLINE: Arachidonic Acid, Cardiovascular Diseases. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 381 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiometabolic disease has become a major health burden worldwide, with sharply increasing prevalence but highly limited therapeutic interventions. Emerging evidence has revealed that arachidonic acid derivatives and pathway factors link metabolic disorders to cardiovascular risks and intimately participate in the progression and severity of cardiometabolic diseases. In this review, we systemically summarized and updated the biological functions of arachidonic acid pathways in cardiometabolic diseases, mainly focusing on heart failure, hypertension, atherosclerosis, nonalcoholic fatty liver disease, obesity, and diabetes. We further discussed the cellular and molecular mechanisms of arachidonic acid pathway–mediated regulation of cardiometabolic diseases and highlighted the emerging clinical advances to improve these pathological conditions by targeting arachidonic acid metabolites and pathway factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachidonic AcidCardiovascular DiseasesHumansAnimalsSignal TransductionMetabolic DiseasesCardiometabolic Risk FactorsObesity

Stichwörter der Autor:innen

arachidonic acidcardiovascular diseasesclinical trialmetabolic diseasestherapeutics

Substanzen

Arachidonic Acid

Autor:innen und Institutionen

  • State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China (Y.H., X.C., H.Y., Z.-G.S…
  • Key Laboratory of Cardiovascular Disease Prevention and Control, Ministry of Education, First Affiliated Hospital of Gannan Medical University, Ganzhou, China (Y.H., X.C., H.Y.).
  • Department of Cardiology, Renmin Hospital of Wuhan University, China (W.L., Z.-G.S., H.L.).
  • Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China (J.C.).
  • Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China (H.L.).
  • School of Basic Medical Sciences, Wuhan University, China (X.-J.Z.).

ORCID-Profile: Yufeng Hu, Hailong Yang, Zhi-Gang She, Jingjing Cai, Hongliang Li

Zitieren

APA

Hu, Y., Li, W., Cheng, X., Yang, H., She, Z. G., Cai, J., Li, H., & Zhang, X. J. (2024). Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases. Circulation Research, 135(1), 222-260. https://doi.org/10.1161/circresaha.124.324383

Vancouver

Hu Y, Li W, Cheng X, Yang H, She ZG, Cai J, et al. Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases. Circulation Research. 2024;135(1):222-260. doi:10.1161/circresaha.124.324383

BibTeX
@article{Hu2024,
  author = {Hu, Yufeng and Li, Wei and Cheng, Xu and Yang, Hailong and She, Zhi-Gang and Cai, Jingjing and Li, Hongliang and Zhang, Xiao-Jing},
  title = {Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {1},
  pages = {222--260},
  doi = {10.1161/circresaha.124.324383}
}
Kostenlos starten →